Peristomal bullous pemphigoid.
Marzano
Angelo V
AV
Vezzoli
Pamela
P
Colombo
Antonella
A
Serini
Stefano M
SM
Crosti
Carlo
C
Berti
Emilio
E
D000369:Aged, 80 and over; D001323:Autoantibodies / Q000097:blood; D001324:Autoantigens / Q000032:analysis / Q000276:immunology; D002990:Clobetasol / Q000627:therapeutic use; D003125:Colostomy / Q000009:adverse effects; D003176:Complement C3 / Q000032:analysis; D004804:Eosinophils / Q000473:pathology; D004890:Erythema / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008214:Lymphocytes / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D024041:Non-Fibrillar Collagens / Q000032:analysis / Q000276:immunology; D010391:Pemphigoid, Bullous / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016896:Treatment Outcome; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D002990:Clobetasol; D003176:Complement C3; D007074:Immunoglobulin G; D008775:Methylprednisolone; D024041:Non-Fibrillar Collagens; D000097805:Collagen Type XVII; C038245:C3 protein, human